A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Safety and efficacy of Efruxifermin in subjects with Non-Invasively diagnosed Non-alcoholic Steatohepatitis (NASH)/Non-alcoholic Fatty Liver Disease (NAFLD)

Project: Research

Project Details

StatusActive
Effective start/end date17/11/2317/11/25

Keywords

  • clinical trial
  • Non-alcoholic Fatty Liver Disease
  • Efruxifermin